PAR

1.92%

25.5¢ paradigm biopharmaceuticals limited..

PAR is far better than you know!, page-3

First 3 Last

Share
Profile

Follow
Vogelworld

1,312 Posts.

263

18/10/19

12:12

Post #: 40950863
Share

Originally posted by jtl: ↑

I thought I would give another inside into my story, having been under the SAS program from early last year. It worked well with no side affects, it changed my life.
If you have severe OA like mine, it is a terrible pain that I can not explain and you will do anything to relive the pain. I used heavy pain killers and anti inflammatories to alleviate pain, however this is only a short term fix and comes with terrible drowsiness and other health problems. The amount of pain killers I would need, would turn me into a walking zombie. The anti inflammatories did not work, and I tried a few different ones.
I am a true believer of PPS and hope PAR have all the success to bring this drug into commercialisation. I have invested in PAR, not just from an monetary point of view but from a user that needs this company to succeed. I want to keep my knee!!
Back in March of this year I was able to get another dose or booster if you want to call it. They did not have enough of PPS at the time, I was told due to them obtaining new vials (FDA requirement) for the US market and also to accommodate the phase 3 trials in the US, plus increased demand with SAS program Australia wide.
PAR is not going to order a absurd amount of PPS until they have a guarantee of a consistent supply chain with the appropriate authorities backing IMO.
I was given only four doses and can tell you, I feel great and just as good as my 12 doses from last year. I was injected in the backside instead of the stomach as last years doses did leave red marks on the stomach and were slightly itchy. It worked well and no marks or itchiness on my backside (very top part of the buttocks, almost lower back, if you want to know) IMO the drug is far better than expected and I believe it will grab a wider market if this is the case. Sure you investors will lose on the $$ per dose, however it will also attract a larger market due to cost savings IMO.
Not only that I feel we will be able to inject in different sites that suit the user and still have the same affects IMO.

Expand

WOW! Thank you for sharing your story, @jtl

It's interesting that you only had four "booster" shots. You didn't have to go through the full course again? Or, was it a case of four shots, you're feeling better, no need for more?

Also, if you don't mind me asking...are you off ALL pain killers/anti-inflammatories?

And, lastly, if your pain level was a 10/10 prior to your first round of treatment, how would you rate it now?

Thanks again for sharing. So glad it's worked so well for you!!!

PAR Price at posting: $2.66 Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

RCE

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

There are more pages in this discussion • 98 more messages in this thread...

First 3 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 25.5¢		Change -0.005(1.92%)		Mkt cap ! $89.19M

Open	High	Low	Value	Volume
27.0¢	27.0¢	25.5¢	$261.4K	990.7K

Buyers (Bids)

No.	Vol.	Price($)
1	9999	25.5¢

Sellers (Offers)

Price($)	Vol.	No.
26.0¢	9445	1

View Market Depth

No.	Vol.	Price($)
1	9999	0.255
5	259000	0.250
4	96000	0.245
9	261374	0.240
5	71970	0.235

Price($)	Vol.	No.
0.260	9445	1
0.275	44000	2
0.280	35900	3
0.285	6729	2
0.290	60000	2

Last trade - 16.10pm 28/06/2024 (20 minute delay)

PAR (ASX) Chart

PAR is far better than you know!, page-3

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Ava Risk Group expands US presence with A$0.7M Substation Deal

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PAR is far better than you know!, page-3

Top Stories

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Ava Risk Group expands US presence with A$0.7M Substation Deal

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News